Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
作者信息
Gupta Sarthak, Nakabo Shuichiro, Chu Jun, Hasni Sarfaraz, Kaplan Mariana J
机构信息
Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA
Systemic Autoimmunity Branch, National Institute of Arthritis and Musculoskeletal and Skin Diseases, National Institutes of Health, Bethesda, Maryland, USA.
出版信息
Ann Rheum Dis. 2023 Oct;82(10):e215. doi: 10.1136/annrheumdis-2020-219648. Epub 2021 Jan 15.
Abstract
摘要
相似文献
1
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
Ann Rheum Dis. 2023 Oct;82(10):e215. doi: 10.1136/annrheumdis-2020-219648. Epub 2021 Jan 15.
2
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine'.
Ann Rheum Dis. 2023 Nov;82(11):e225. doi: 10.1136/annrheumdis-2021-220410. Epub 2021 Apr 21.
3
Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'.
Ann Rheum Dis. 2021 Mar;80(3):e33. doi: 10.1136/annrheumdis-2020-217827. Epub 2020 May 29.
4
Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Mathian .
Ann Rheum Dis. 2022 Nov;81(11):e216. doi: 10.1136/annrheumdis-2020-218778. Epub 2020 Aug 28.
5
Response to: 'Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine' by Carbillon .
Ann Rheum Dis. 2021 Apr;80(4):e55. doi: 10.1136/annrheumdis-2020-217990. Epub 2020 May 31.
6
Response to: 'Correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus under long-term treatment with hydroxychloroquine'' by Nikpour .
Ann Rheum Dis. 2021 Mar;80(3):e34. doi: 10.1136/annrheumdis-2020-217875. Epub 2020 May 29.
7
Response to: 'Antirheumatic drugs, B cell depletion and critical COVID-19: correspondence on 'Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine by Mathian ' by Notz .
Ann Rheum Dis. 2022 Nov;81(11):e217. doi: 10.1136/annrheumdis-2020-218795. Epub 2020 Nov 25.
8
Clinical course of COVID-19 in patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
Ann Rheum Dis. 2021 Apr;80(4):e54. doi: 10.1136/annrheumdis-2020-217847. Epub 2020 May 31.
9
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
10
Response to: 'COVID-19 among Malaysian patients with systemic lupus erythematosus on hydroxychloroquine' by Teh .
Ann Rheum Dis. 2021 May;80(5):e70. doi: 10.1136/annrheumdis-2020-218173. Epub 2020 Jul 31.
引用本文的文献
1
Interferon pathway lupus risk alleles modulate risk of death from acute COVID-19.
Transl Res. 2022 Jun;244:47-55. doi: 10.1016/j.trsl.2022.01.007. Epub 2022 Jan 31.
2
Impact of the COVID-19 pandemic in patients with systemic lupus erythematosus throughout one year.
Clin Immunol. 2021 Oct;231:108845. doi: 10.1016/j.clim.2021.108845. Epub 2021 Aug 31.
本文引用的文献
1
Autoantibodies against type I IFNs in patients with life-threatening COVID-19.
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4585. Epub 2020 Sep 24.
2
Inborn errors of type I IFN immunity in patients with life-threatening COVID-19.
Science. 2020 Oct 23;370(6515). doi: 10.1126/science.abd4570. Epub 2020 Sep 24.
3
Leveraging the United States Epicenter to Provide Insights on COVID-19 in Patients With Systemic Lupus Erythematosus.
Arthritis Rheumatol. 2020 Dec;72(12):1971-1980. doi: 10.1002/art.41450. Epub 2020 Oct 28.
4
Clinical course of coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under long-term treatment with hydroxychloroquine.
Ann Rheum Dis. 2020 Jun;79(6):837-839. doi: 10.1136/annrheumdis-2020-217566. Epub 2020 Apr 24.
5
Distinct Functions of Autoantibodies Against Interferon in Systemic Lupus Erythematosus: A Comprehensive Analysis of Anticytokine Autoantibodies in Common Rheumatic Diseases.
Arthritis Rheumatol. 2016 Jul;68(7):1677-87. doi: 10.1002/art.39607.
6
Broad-spectrum antibodies against self-antigens and cytokines in RAG deficiency.
J Clin Invest. 2015 Nov 2;125(11):4135-48. doi: 10.1172/JCI80477. Epub 2015 Oct 12.
7
Interferons and viruses: an evolutionary arms race of molecular interactions.
Trends Immunol. 2015 Mar;36(3):124-38. doi: 10.1016/j.it.2015.01.004. Epub 2015 Feb 20.
8
Type I interferon in the pathogenesis of lupus.
J Immunol. 2014 Jun 15;192(12):5459-68. doi: 10.4049/jimmunol.1002795.
Zotero 插件